Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity

Neurochemical Research

Volumn 21, Issue 6, 1996, Pages 691-693

  Chatterjie, Nithiananda ^a   Alexander, George J ^a   Sechzer, Jeri A ^b   Lieberman, Kenneth W ^c  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b PACE UNIVERSITY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; dextro naloxone; hyperactivity; naloxone; opiate antagonist

Indexed keywords

AMPHETAMINE; COCAINE; ENDORPHIN; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ENANTIOMER; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOMER; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COCAINE; HYPERKINESIS; MALE; MICE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; STEREOISOMERISM;

EID: 0029894508     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02527726     Document Type: Article

References (20)

1. Alexander, G.J., and Chatterjie, N. 1991. Spontaneous motility in SW mice: amphetamine/naloxone antagonism. FASEB J. 5:A862.
2. Chatterjie, N., and Alexander, G.J. 1983. Naloxone-6-spiro-hydantoin: a new non-toxic compound with anticonvulsive properties. Neuropharmacol. 22:1151-1153.
3. Chatterjie, N., Laorden, M.L., Puig, M.M., and Alexander, G.J. 1989. Prevention of hyperthermia-induced seizures in immature rats by a hydantoin derivative of naloxone. Life Sci. 45:857-862.
4. Hooks, M.S., Jones, D.N., Justice, J.B., and Holtzman, S.G. 1992. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 41:449-453.
5. Jones, D.N., and Holtzman, S.G. 1992. Effects of naloxone infusion upon spontaneous and apetamine-induced activity. Eur. J. Pharmacol. 221:161-165.
6. Jones, D.N., and Holtzman, S.G. 1994. Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacol. 114:215-225.
7. Chatterjie, N., Alexander, G.J., Sechzer, J.A., and Lieberman K.W. 1995. Amphetamine/naloxone interaction: Prolonged protection by naloxyl-6α-spirohydantoin. FASEB J. 9:A1372.
8. Iijima, I., Minamikawa, J., Jacobson, A.E., Brossi, A., and Rice, K.C. 1978. Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J. Med. Chem. 21:398-400.
9. Alexander, G.J., and Chatterjie, N. 1991. (+)-Naloxone antagonizes amphetamine-induced increase in spontaneous motility. FASEB J. 5:A682.
10. Chatterjie, N., and Alexander, G.J. 1992. Non-opiate effects of naloxone: antagonism of amphetamine-enhanced spontaneous activity in SW mice. FASEB J. 6:A994.
11. Scalzo, F.M., Ali, S.F., Frambes, N.A., and Spear, L.P. 1990. Weanling rats exposed prenatally to cocaine exhibit an increase in striatal D2 dopamine binding associated with an increase in ligand affinity. Pharmacol. Biochem. Behav. 37:371-373.
12. Houdi, A.A., Bardo, M.T., and van Loon, G.R. 1989. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res. 497:195-198.
13. Kosten, T.A., Kleber, H.D., and Morgan, C. 1989. Role of opioid antagonists in treating intravenous cocaine abusers. Life Sci. 44: 887-892.
14. Kosten, T.A. 1990. Cocaine attenuates severity of naloxone-precipitated opioid withdrawal. Life Sci. 47:1617-1623.
15. Ramsey, N.F., and van Ree, J.M. 1991. Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 40:807-810.
16. Bain, G., and Kornetsky, C. 1987. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci. 40: 1119-1125.
17. Bilsky, E.J., Montegut, M.J., Delong, C.L., and Reid, L.D. 1992. Opioidergic modulation of cocaine conditioned place preference. Life Sci. 50:85-90.
18. Brasch, H., 1986. Influence of the optical isomers of (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea pig isolated cardiac preparation. Brit. J. Pharmacol. 88:733-740.
19. Sarne, T., Hochman, I., Eshed, M., and Oppenheimer, E. 1988. Anti-arrhythmic action of naloxone: direct effect on the rat heart. Life Sci. 43:859-864.
20. Cregler, L.L., and Mark, H. 1986. Special report: Medical complications of cocaine abuse. New Engl. J. Med. 303:1495-1500.